Global Antimicrobial Technology Market Analysis Report 2022: Opportunities in Wide Adoption in Antimicrobial Additives, Coatings, and Films in Consumer Health Applications

Company Logo

Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Growth Opportunities for Global Antimicrobial Technologies Enabled by COVID-19" report has been added to ResearchAndMarkets.com's offering.

Antimicrobial technology has previously seen wide adoption in antimicrobial additives, coatings, and films in consumer health applications.

However, with the emergence of COVID-19, the demand for antimicrobial technology has driven innovations, such as graphene nanoparticles (NPs), photocatalytic additives, and antimicrobial polymer nanomaterials, in developing high-temperature resistance, non-toxic antimicrobial disinfectants, and long-lasting antimicrobial technology adoption in consumer health, building and construction, automotive, and consumer goods applications.

Antimicrobial technology materials include antimicrobial polymers; composites, metal-based antimicrobial agents; nanomaterials; natural-based antimicrobial agents; antimicrobial peptides (AMPs); and other materials, such as phenolics, amidines, and biguanides.

Due to their stable structure, metal ions and metal-oxide ions have found use in medical and food packaging applications. The use of ultra-thin two-dimensional materials like black phosphorus and graphene on antimicrobial surfaces has been a focus of technology development initiatives following the outbreak of COVID-19.

In addition to antimicrobial surfaces, implants, medical devices, food packaging, building and construction materials, and textiles have all experienced a spike in interest for antimicrobial coatings.

The need for active packaging that exhibits high antimicrobial features for food and personal care applications following COVID-19 has prompted industry stakeholders and researchers to continue pursuing their work with natural antimicrobials such as chitin-chitosan and peptides to develop biodegradable, safe, yet high-performance antimicrobial films.

The research will answer the following questions:

• What factors will drive antimicrobial technology adoption post COVID-19?

• What challenges and impediments restrain antimicrobial technology adoption?

• What initiatives are industry participants undertaking to accelerate adoption across industries?

• What previous challenges does antimicrobial technology adoption across applications address?

• What growth potential exists for commercializing antimicrobial technologies across industries?

Key Topics Covered:

1. Strategic Imperatives

• Why Is It Increasingly Difficult to Grow? The Strategic Imperative: Factors Creating Pressure on Growth

• The Strategic Imperative

• The Impact of the Top 3 Strategic Imperatives on Antimicrobial Technologies Enabled by COVID-19

• Growth Opportunities Fuel the Growth Pipeline Engine

• Research Methodology

2. Research Scope and Segmentation

• Research Context and Key Questions the Study Will Answer

• Research Segmentation

3. Research Summary

• Technology Dashboard

• Impact of COVID-19 on the Antimicrobial Technologies Landscape

• COVID-19 Drives Interest in Antimicrobial Technologies across Regions

• Key Findings

4. Growth Opportunity Analysis: Impact of COVID-19 on Antimicrobial Technologies

• COVID-19 Has Resulted in an Unprecedented Demand for Antimicrobial Technologies

• Accelerated AMR Risk and Infection Spread Propelled Antimicrobial Use in Emerging Markets Pre- and During COVID-19

• Technologies to Accommodate Antimicrobial Features in Various Applications

• Metal Ions, Polymers, Naturals, AMPs, and Nanoantimicrobials Could Act as Disruptors to Mitigate Infections

• Technologies Could Solve Existing AMR Challenges Post-COVID-19

• Mode of Action of Antimicrobials Defines Clinical Efficacy via Syntheses

• Antimicrobials Pave the Way for a New Application Landscape beyond Healthcare

• Regulatory Aspects Make High-performance Antimicrobial Commercialization Time-consuming

5. Technology Assessment: Antimicrobial Technologies

• Metal Ions, Especially Copper and Ag, Help Create New Antimicrobial Technologies

• Interest in Metal and Metal-oxide Ion Adoption as an Antimicrobial for Their Stable Structure

• Nanomaterials Provide Multiple Bactericidal Pathways to Combat Microbes and Infections

• Antimicrobial Nanomaterials for High-performance Solutions

• Food Quality and Safety Awareness Create Demand for Natural Antimicrobials

• Interest in Use of Natural Antimicrobial Materials for Degradable Antimicrobial Technology

• The Multifaceted Nature of AMPs Drives Their Long-term Applicability

• AMP Adoption Is Increasing in Healthcare and Food Packaging Applications

• Antimicrobial Polymers Have Proven Capabilities to Protect Against the Negative Impact of Pathogenic Microorganisms

• Simplifying Antimicrobial Polymer Fabrication and Application Processes

• To Evaluate the Effect of Antimicrobial Susceptibility on Outcomes, Benchmarking Key Performance Indicators Is Pivotal

• Antimicrobial Agents' Relevance in Various Industrial Sectors

6. Innovation Ecosystem

• Commercialized Metal-ion Antimicrobial Technologies

• High-performance Antimicrobial Coating Development Using Metal Ions

• Nanomaterials for Cost-efficient, High-performance Antimicrobial Technology Development

• Studies Focusing on Antimicrobial Nanomaterial Adoption in Food and Energy Applications

• Increase in Degradable Antimicrobial Film Development

• Stakeholders Investigating the Potential Adoption of Antimicrobial Peptides for Food Packaging

• High Interest in Research Studies on Antimicrobial Polymers in APAC

• Antimicrobial Coatings Remain an Area of High R&D

7. IP Analysis

• Steady Rise in Research Studies Related to Antimicrobial Technologies

• Metal Ions and Natural Antimicrobial Technologies Lead in IP Filing across the Globe

• US and European Patent Offices Show Steady Rise in IP Filings in Last 5 Years

• Natural Antimicrobials Are Gaining IP Focus Because of Increased Interest in Developing Environment-friendly Technologies

8. Funding and Investment Analysis

• Investors Bet Big on Antimicrobials to Reinforce Health and Safety During the Pandemic

• Funding Is Predominantly Inclined towards New Product Innovation

• Healthcare Companies Are Prominent Beneficiaries to Investigate Enhanced Antimicrobials for Combatting AMR

• Antimicrobial Spending to Escalate to Eliminate Superbug Threats

• Government Initiatives and Funding and Private Funding Encourage Cost-efficient Antimicrobial Technology Development

• Accelerators and Incubators Expedite Material and Digitization Initiative Growth

9. Growth Opportunity Universe

• Growth Opportunity 1: Ultra-thin, Durable, High-performance Antimicrobial Technology Development

• Growth Opportunity 2 Nanomaterial Integration During Fabrication for Cost-efficient and High-performance Antimicrobial Technologies

• Growth Opportunity 3: R&D Activities to Use Metal and Metal-oxide Ions to Develop Self-sanitizing Technology

• Growth Opportunity 4: Digital Interventions on Antimicrobial Stewardship Can Drive New Product Development

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/wpthk2

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900